Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Sankyo's calpain inhibitor for neurological disorders, restenosis

May 24, 1996

E. Merck describes NMDA ligands for neurodegeneration

May 24, 1996

Lilly's new series of muscarinic cholinergic receptor agonists

May 24, 1996

Biogen introduces Avonex in first market

May 24, 1996

ICN will market fluoxetine in Russia, ex-Yugoslavia

May 24, 1996

Fujisawa, Nihon Shokubai claim CCK-B antagonists

May 24, 1996

ADIR claims melatonin receptor ligands for CNS disorders

May 24, 1996

Ultiva okayed for marketing in Germany; U.S. approval recommended by committee

May 24, 1996

Rizatriptan NDA filing expected in mid-1997

May 24, 1996

L-742694: Morpholine-based NK1 antagonist

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...